Specialty Pharmacy

Processing speed found to hinder MS patients in everyday life.

Process could lead to new treatments for diabetes and other diseases.

Proper nutrition leads to improved outcomes and increased CD4 T-cell counts.

Researchers evaluate how cancer cells adapt and survive in a new bone environment.

Walgreens will pay a $500,000 settlement concerning a civil complaint that the retail pharmacy giant was not compliant with California regulations related to pharmacist consultations.

Each year, the American Society of Health-System Pharmacists provides a tremendous service to pharmacists by publishing a list of significant articles on infectious diseases pharmacotherapy from the previous year.

Ongoing clinical trial testing guadecitabine in Myelodysplastic syndromes and acute myelogenous leukemia.

Epidermal growth factor receptors may offer cancer treatment target.

A look back at recent developments in cancer research.

An HCV infection may cause more than just liver damage.

Children vaccinated before starting HIV therapy found to be at risk.

Top stories of the week on Specialty Pharmacy Times from August 17 to 21.

Out-of-pocket costs projected to drop from 11.6% in 2013 to 10% in 2024.

Treatment uses photodynamic therapy with compounds that make cancer cells vulnerable to reactive oxygen species.

Researchers seek to improve treatment for autoimmune diseases, including rheumatoid arthritis, gout, Crohn's disease, and lupus.

A 10-second assessment may be as effective as more complex tests.

The FDA is considering expanding the use of Merck's pembrolizumab as a first-line treatment for advanced melanoma.

More companies are requiring prior authorization before specialty drugs are purchased under employer health plan.

Medicare Part D contracting transparencies among issues that prompted action.

Rheumatoid arthritis treatment remains consistently well tolerated over long-term evaluation.

Nephropathic cystinosis drug Procysbi now available in delayed-release capsules for young children.

Changes still needed to further improve the decision-making process for patients.

Depression and fatigue loom as issues to overcome for patients with multiple sclerosis.

Women and individuals who suffered childhood sexual abuse among most vulnerable IBD patients.

Specialty pharmacies need to carefully evaluate multiple aspects of manufacturer-sponsored free product programs.

Study finds coffee consumption improves survival odds in some patients.

Research may lead to a gel that instantly destroys viral particles.

In the long wake of a deadly meningitis outbreak from tainted drugs distributed by a compounding pharmacy in Massachusetts, state regulators have been increasing their inspections of pharmacies with complaints.